EA199800869A1 - UGREY TREATMENT - Google Patents

UGREY TREATMENT

Info

Publication number
EA199800869A1
EA199800869A1 EA199800869A EA199800869A EA199800869A1 EA 199800869 A1 EA199800869 A1 EA 199800869A1 EA 199800869 A EA199800869 A EA 199800869A EA 199800869 A EA199800869 A EA 199800869A EA 199800869 A1 EA199800869 A1 EA 199800869A1
Authority
EA
Eurasian Patent Office
Prior art keywords
treatment
nadp
ugrey
nad
nicotinamide
Prior art date
Application number
EA199800869A
Other languages
Russian (ru)
Inventor
Джон Александер Стэйтон
Джеймс Стивен Роуве
Original Assignee
Мэйнстар Уан Инвестментс Пти. Лтд
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Мэйнстар Уан Инвестментс Пти. Лтд filed Critical Мэйнстар Уан Инвестментс Пти. Лтд
Publication of EA199800869A1 publication Critical patent/EA199800869A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/673Vitamin B group
    • A61K8/675Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/61Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/10Anti-acne agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Birds (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)

Abstract

Композиция для местного лечения угрей, содержащая 0,5-20 вес.% никотинамидадениндинуклеотида (НАД), никотинамидадениндинуклеотид фосфата (НАДФ) или такого его предшественника, который при применении продуцирует НАД или НАДФ, 0,1-25 вес.% масла чайного куста и фармацевтически приемлемый носитель.Международная заявка была опубликована вместе с отчетом о международном поиске.A composition for the topical treatment of acne, containing 0.5–20 wt.% Nicotinamide adenine dinucleotide (NAD), nicotinamide aden din dinucleotide phosphate (NADP) or one of its precursors that, when used, produces NAD or NADP; a pharmaceutically acceptable carrier. The international application was published along with an international search report.

EA199800869A 1996-03-25 1997-03-24 UGREY TREATMENT EA199800869A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPN8924A AUPN892496A0 (en) 1996-03-25 1996-03-25 Acne treatment
PCT/AU1997/000190 WO1997035597A1 (en) 1996-03-25 1997-03-24 Acne treatment

Publications (1)

Publication Number Publication Date
EA199800869A1 true EA199800869A1 (en) 1999-06-24

Family

ID=3793237

Family Applications (1)

Application Number Title Priority Date Filing Date
EA199800869A EA199800869A1 (en) 1996-03-25 1997-03-24 UGREY TREATMENT

Country Status (10)

Country Link
EP (1) EP0901377A1 (en)
JP (1) JP2000507248A (en)
CN (1) CN1219880A (en)
AU (1) AUPN892496A0 (en)
CA (1) CA2250383A1 (en)
EA (1) EA199800869A1 (en)
NZ (1) NZ332353A (en)
PL (1) PL328964A1 (en)
WO (1) WO1997035597A1 (en)
ZA (1) ZA972515B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000032179A2 (en) * 1998-12-01 2000-06-08 University Of Kentucky Research Foundation Use of nicotonic acid derivatives for the treatment of dna damage in skin cells
ATE337784T1 (en) * 2000-04-14 2006-09-15 Niadyne Corp METHODS AND COMPOSITIONS FOR IMPROVED OXYGEN DELIVERY FOR CELLS
ES2364269T3 (en) * 2002-06-17 2011-08-30 Naicons S.C.A.R.L. USE OF AMIDA DERIVATIVES OF GE 2270 FACTOR A3 FOR THE TREATMENT OF ACNE.
WO2009086595A1 (en) * 2008-01-07 2009-07-16 Robert Alan Armstrong Treatment for dermatological conditions
IT1401957B1 (en) * 2010-09-23 2013-08-28 Forem Pharma S R L COMPOSITION FOR ACNE TREATMENT.
CN103099756B (en) * 2013-02-01 2014-07-16 广州市白云区天芳化妆品厂 Acne-removing and anti-allergic cosmetic cream and preparation method thereof
CN106413680A (en) * 2014-05-12 2017-02-15 荷兰联合利华有限公司 Niacinamide for inducing generation of antimicrobial peptides
KR101604212B1 (en) 2015-07-17 2016-03-17 울산대학교 산학협력단 Composition for the prevention and treatment of obesity or impaired glucose tolerance containing NAD
CN108619062B (en) * 2018-07-17 2020-06-19 广州澳希亚实业有限公司 Acne-removing composition and application thereof
CN112245311A (en) * 2020-11-19 2021-01-22 泉后(广州)生物科技研究院有限公司 Acne removing composition
WO2023135186A1 (en) * 2022-01-12 2023-07-20 S-Biomedic Nv Skin care composition and uses thereof

Also Published As

Publication number Publication date
NZ332353A (en) 2000-02-28
EP0901377A1 (en) 1999-03-17
CN1219880A (en) 1999-06-16
AUPN892496A0 (en) 1996-04-18
JP2000507248A (en) 2000-06-13
ZA972515B (en) 1998-01-26
CA2250383A1 (en) 1997-10-02
PL328964A1 (en) 1999-03-01
WO1997035597A1 (en) 1997-10-02

Similar Documents

Publication Publication Date Title
AU674463B2 (en) Mediators suitable for the electrochemical regeneration of NADH, NADPH or analogs thereof
AU6783698A (en) Polyaromatic antiviral compositions
AU4950993A (en) Combination of germicidal agents
EP1600448A3 (en) Enantiomerically pure beta-D-(-)-Dioxolane-Nucleosides
AU692387B2 (en) Mediators suitable for the electrochemical regeneration of NADH, NADPH or analogs thereof
AU1296902A (en) Isoquinolinone potassium channel inhibitors
YU40203A (en) Ortho-substituted nitrogen-containing bisaril compounds used as potassium channel inhibitors
EA199800869A1 (en) UGREY TREATMENT
AU3293695A (en) Mediators suitable for the electrochemical regeneration of NADH, NADPH or analogs thereof
WO2001024763A3 (en) Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
MXPA02012203A (en) Glucagon-like peptide-1 analogs.
CA2348735A1 (en) Heterocyclic potassium channel inhibitors
YU19499A (en) Benzonaphthyridines as bronchial therapeutics
ES2156633T3 (en) DERIVATIVES OF TIAZOLIDINE-4-CARBOXYL ACID AS CITOPROTECTING AGENTS.
CA2338721A1 (en) New cofactors for methyltransferases
AU9066498A (en) Substituted 6-alkylphenanthridines
CA2385996A1 (en) Anticancer agents
EP0588796A4 (en) New compounds and compositions useful as antifungal and antimycobacterial agents
CA2048242A1 (en) 4-amino-4-steroids and their use as 5.alpha.-reductase inhibitors
JPS5635985A (en) Stabilization of glutamic acid dehydrogenase
MY106564A (en) Sulfur-substituted mevinic acid derivatives.
CA1272214C (en)
TW239124B (en) Process for the preparation of 2,4,5-tribromopyrrole-3-carbonitrile
GR3022724T3 (en) Antidepressive composition containing nicotinamid-adenin-dinucleotide
EP0810211A3 (en) Organic peroxide stabilization with phosphomolybdic acid